Systemic Markers of Collagen Metabolism and Vitamin C in Smokers and Non-Smokers With Pelvic Organ Prolapse
NCT01548105 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 96
Last updated 2014-10-17
Summary
Data on smoking and POP are conflicting. In a study done by Alnaif et al, smoking was found to be associated with severe POP. The authors' proposed explanation was that smoking impairs tissue and wound healing. Our primary objective is to document whether smokers with pelvic organ prolapse (POP) are different from non-smokers with POP with respect to collagen biosynthesis and breakdown using systemic markers of collagen metabolism and Vitamin C.
Conditions
- Pelvic Organ Prolapse
Interventions
- OTHER
-
Blood draw for the study participants
These will include: * Procollagen 1-N propeptide levels (PINP) * Matrix metalloproteinase (MMP9) * Plasma Vitamin C levels
Sponsors & Collaborators
-
TriHealth Inc.
lead OTHER
Principal Investigators
-
Maria Victoria C Estanol, MD · Good Samaritan Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2013-01-31
- Completion
- 2013-03-31
Countries
- United States
Study Locations
More Related Trials
-
Influence of Genotype of CYP2C9 on Clinical Efficacy and Pharmacokinetics of Piroxicam After Lower Third Molar Surgery
NCT02450487 ·Status: COMPLETED ·Phase: PHASE4
-
Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome
NCT02052908 ·Status: COMPLETED ·Phase: PHASE1
-
Heavy Metal Urine Analysis in 20 Healthy Persons Taking Mineralox
NCT00623675 ·Status: SUSPENDED ·Phase: PHASE4
-
The Impact of Grapefruit Juice on the Response to Clopidogrel
NCT00817999 ·Status: COMPLETED ·Phase: PHASE4
-
A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function
NCT00674856 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Dual Cyclooxygenase-2 and Carbonic Anhydrase Inhibition
NCT00780325 ·Status: TERMINATED ·Phase: PHASE1
-
Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males with Klinefelter Syndrome
NCT05498090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Short-term Impact of Cyplexinol® on Self-reported Joint Pain
NCT04764110 ·Status: COMPLETED ·Phase: NA
-
CYP2C19 Variants and Limonene Metabolism
NCT05078723 ·Status: RECRUITING ·Phase: NA
-
Salivary Phosphorus and Level of Kidney Function
NCT01311973 ·Status: COMPLETED
-
Efficacy of Parecoxib on Patients With CRPS
NCT01523379 ·Status: NO_LONGER_AVAILABLE
-
Pharmacokinetic and Comparative Bioavailability Study of Codeine Sulfate Under Fasted Conditions
NCT01010139 ·Status: COMPLETED ·Phase: NA
-
A Comparative Bioavailability and Pharmacokinetic Study of TNX-102 2.4 mg and Cyclobenzaprine 5 mg Tablets in Healthy Adults.
NCT01490788 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of SP-104
NCT05002946 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging
NCT05307627 ·Status: WITHDRAWN
-
Proellex Pharmacokinetics Bridging Study
NCT01067807 ·Status: COMPLETED ·Phase: PHASE1
-
Changes in mRNA Expression Following Exposure to Naproxen
NCT01090596 ·Status: COMPLETED ·Phase: NA
-
Perioperative Inflammation and Cyclooxygenase 2 (COX-2)
NCT00122096 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans
NCT00872599 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
NCT05411718 ·Status: RECRUITING ·Phase: PHASE2
-
Variability in Response to Non-steroidal Anti-inflammatory Drugs
NCT02502006 ·Status: TERMINATED ·Phase: PHASE1
-
Dose-Proportionality and Food Effect Study of TNX-102 SL
NCT04164719 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Food Interaction Study of Seville Orange Juice and Colchicine
NCT00960193 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Effect of Food Upon the Pharmacokinetics of Androxal
NCT02146391 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics Study of XG005 Capsule
NCT04499209 ·Status: COMPLETED ·Phase: PHASE1